BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 33338707)

  • 1. A multidisciplinary registry of patients with autoimmune and immune-mediated diseases with symptomatic COVID-19 from a single center.
    Sarmiento-Monroy JC; Espinosa G; Londoño MC; Meira F; Caballol B; Llufriu S; Carrasco JL; Moll-Udina A; Quintana LF; Giavedoni P; Ramírez J; Inciarte-Mundo J; Solana E; Blanco Y; Martinez-Hernandez E; Sepúlveda M; Llorenç V; Prieto-González S; Espígol-Frigolé G; Milisenda JC; Cid MC; Mascaró JM; Blanco I; Barberá JA; Sibila O; Gratacos-Ginès J; Adán A; Agustí A; Sanmartí R; Panés J; Cervera R; Vila J; Soriano A; Gómez-Puerta JA;
    J Autoimmun; 2021 Feb; 117():102580. PubMed ID: 33338707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning to understand risks for severe COVID-19 outcomes: a retrospective cohort study of immune-mediated inflammatory diseases, immunomodulatory medications, and comorbidities in a large US health-care system.
    Wei Q; Mease PJ; Chiorean M; Iles-Shih L; Matos WF; Baumgartner A; Molani S; Hwang YM; Belhu B; Ralevski A; Hadlock J
    Lancet Digit Health; 2024 May; 6(5):e309-e322. PubMed ID: 38670740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of hospital PCR-confirmed COVID-19 cases in patients with chronic inflammatory and autoimmune rheumatic diseases.
    Pablos JL; Abasolo L; Alvaro-Gracia JM; Blanco FJ; Blanco R; Castrejón I; Fernandez-Fernandez D; Fernandez-Gutierrez B; Galindo-Izquierdo M; Gonzalez-Gay MA; Manrique-Arija S; Mena Vázquez N; Mera Varela A; Retuerto M; Seijas-Lopez A;
    Ann Rheum Dis; 2020 Sep; 79(9):1170-1173. PubMed ID: 32532753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of patients with immune-mediated inflammatory diseases hospitalized for SARS-CoV-2 infection.
    Robustillo-Villarino M; Álvarez-Arroyo L; Carrera-Hueso FJ; Barreda-Altaba I; Nieto-Cid M; Girona-Sanz AM; El-Qutob D
    Reumatol Clin (Engl Ed); 2022; 18(6):331-337. PubMed ID: 34538610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of hospital-acquired SARS-CoV-2 infection in the Canadian first wave epicentre: a retrospective cohort study.
    Melançon E; Brosseau M; Bartoli A; Labbé AC; Lavallée C; Marchand-Senécal X; Wang HT
    CMAJ Open; 2022; 10(1):E74-E81. PubMed ID: 35105684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
    Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
    Ann Rheum Dis; 2020 Nov; 79(11):1393-1399. PubMed ID: 32769150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study.
    D'Silva KM; Jorge A; Cohen A; McCormick N; Zhang Y; Wallace ZS; Choi HK
    Arthritis Rheumatol; 2021 Jun; 73(6):914-920. PubMed ID: 33305544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial chest radiographs and artificial intelligence (AI) predict clinical outcomes in COVID-19 patients: analysis of 697 Italian patients.
    Mushtaq J; Pennella R; Lavalle S; Colarieti A; Steidler S; Martinenghi CMA; Palumbo D; Esposito A; Rovere-Querini P; Tresoldi M; Landoni G; Ciceri F; Zangrillo A; De Cobelli F
    Eur Radiol; 2021 Mar; 31(3):1770-1779. PubMed ID: 32945968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection.
    Moreno-García E; Rico E; Albiach L; Agüero D; Ambrosioni J; Bodro M; Cardozo C; Chumbita M; De la Mora M; García-Pouton N; Garcia-Vidal C; González-Cordón A; Hernández-Meneses M; Inciarte A; Laguno M; Leal L; Linares L; Macay I; Meira F; Mensa J; Moreno A; Morata L; Puerta-Alcalde P; Rojas J; Solá M; Torres B; Torres M; Tomé A; Tuset M; Castro P; Fernández S; Nicolás JM; Almuedo-Riera A; Muñoz J; Fernandez-Pittol M; Marcos MA; Soy D; Martínez JA; García F; Soriano A
    Rev Esp Quimioter; 2021 Jun; 34(3):238-244. PubMed ID: 33829722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Adverse Outcomes in Hospitalized Patients With Autoimmune Disease and COVID-19: A Matched Cohort Study From New York City.
    Faye AS; Lee KE; Laszkowska M; Kim J; Blackett JW; McKenney AS; Krigel A; Giles JT; Wang R; Bernstein EJ; Green PHR; Krishnareddy S; Hur C; Lebwohl B
    J Rheumatol; 2021 Mar; 48(3):454-462. PubMed ID: 33132221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 infection in patients with autoimmune hepatitis.
    Marjot T; Buescher G; Sebode M; Barnes E; Barritt AS; Armstrong MJ; Baldelli L; Kennedy J; Mercer C; Ozga AK; Casar C; Schramm C; ; Moon AM; Webb GJ; Lohse AW
    J Hepatol; 2021 Jun; 74(6):1335-1343. PubMed ID: 33508378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.
    Singer AJ; Morley EJ; Meyers K; Fernandes R; Rowe AL; Viccellio P; Thode HC; Bracey A; Henry MC
    Ann Emerg Med; 2020 Oct; 76(4):394-404. PubMed ID: 32563601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
    Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
    JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases.
    Clemente D; Udaondo C; de Inocencio J; Nieto JC; Del Río PG; Fernández AG; Palomo JA; Bachiller-Corral J; Lopez Robledillo JC; Millán Longo C; Leon L; Abasolo L; Boteanu A
    Pediatr Rheumatol Online J; 2021 Nov; 19(1):162. PubMed ID: 34838054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and Outcomes of SARS-CoV-2 Infection in Patients with Sarcoidosis.
    Brito-Zerón P; Gracia-Tello B; Robles A; Alguacil A; Bonet M; De-Escalante B; Noblejas-Mosso A; Gómez-de-la-Torre R; Akasbi M; Pérez-de-Lis M; Pérez-Alvarez R; Ramos-Casals M; On Behalf Of The SarcoGEAS-Semi Registry
    Viruses; 2021 May; 13(6):. PubMed ID: 34071924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.
    Seon JY; Jeon WH; Bae SC; Eun BL; Choung JT; Oh IH
    J Korean Med Sci; 2021 May; 36(20):e148. PubMed ID: 34032033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.